Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Can This Healthcare Stock Keep Beating the Market?


While the broader market is struggling, Krystal Biotech (NASDAQ: KRYS) is performing relatively well. Shares of the gene-editing specialist are in the green for the year. It's been a volatile ride, though, and there could be more twists and turns for Krystal Biotech in the next 10 months. On the other hand, there are good reasons the biotech might continue to deliver market-beating returns. Should investors bet on Krystal Biotech right now?

KRYS Chart

KRYS data by YCharts

Continue reading


Source Fool.com

Like: 0
Share

Comments